166 related articles for article (PubMed ID: 23235148)
21. A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy.
Lo Piccolo L; Umegawachi T; Yeewa R; Potikanond S; Nimlamool W; Prachayasittikul V; Gotoh Y; Yoshida H; Yamaguchi M; Jantrapirom S
Neurotherapeutics; 2023 Sep; 20(5):1330-1346. PubMed ID: 37493896
[TBL] [Abstract][Full Text] [Related]
22. ALS-linked TDP-43 mutations interfere with the recruitment of RNA recognition motifs to G-quadruplex RNA.
Ishiguro A; Ishihama A
Sci Rep; 2023 Apr; 13(1):5982. PubMed ID: 37046025
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Effect of Rapamycin on TDP-43-Related Pathogenesis in Ischemic Stroke.
Tsou YS; Lai JH; Chen KY; Chang CF; Huang CC
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614118
[TBL] [Abstract][Full Text] [Related]
24. Molecular Dissection of TDP-43 as a Leading Cause of ALS/FTLD.
Tamaki Y; Urushitani M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293362
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation.
Zanini G; Selleri V; Nasi M; De Gaetano A; Martinelli I; Gianferrari G; Lofaro FD; Boraldi F; Mandrioli J; Pinti M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233180
[TBL] [Abstract][Full Text] [Related]
26. Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies.
Tran NN; Lee BH
Front Cell Dev Biol; 2022; 10():931968. PubMed ID: 36158183
[TBL] [Abstract][Full Text] [Related]
27. Profiling morphologic MRI features of motor neuron disease caused by
Spinelli EG; Ghirelli A; Riva N; Canu E; Castelnovo V; Domi T; Pozzi L; Carrera P; Silani V; Chiò A; Filippi M; Agosta F
Front Neurol; 2022; 13():931006. PubMed ID: 35911889
[TBL] [Abstract][Full Text] [Related]
28. Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice.
Yang C; Qiao T; Yu J; Wang H; Guo Y; Salameh J; Metterville J; Parsi S; Yusuf I; Brown RH; Cai H; Xu Z
PLoS One; 2022; 17(2):e0255710. PubMed ID: 35113871
[TBL] [Abstract][Full Text] [Related]
29. Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Patients.
Bourbouli M; Paraskevas GP; Rentzos M; Mathioudakis L; Zouvelou V; Bougea A; Tychalas A; Kimiskidis VK; Constantinides V; Zafeiris S; Tzagournissakis M; Papadimas G; Karadima G; Koutsis G; Kroupis C; Kartanou C; Kapaki E; Zaganas I
Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573259
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of TDP-43 Proteinopathy Onset and Propagation.
Chen HJ; Mitchell JC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199367
[TBL] [Abstract][Full Text] [Related]
31. Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD.
Wood A; Gurfinkel Y; Polain N; Lamont W; Lyn Rea S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946763
[TBL] [Abstract][Full Text] [Related]
32. DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation.
Deshimaru M; Kinoshita-Kawada M; Kubota K; Watanabe T; Tanaka Y; Hirano S; Ishidate F; Hiramoto M; Ishikawa M; Uehara Y; Okano H; Hirose S; Fujioka S; Iwasaki K; Yuasa-Kawada J; Mishima T; Tsuboi Y
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924373
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the upstream and intron promoters of the gene encoding TAR DNA-binding protein.
Hasegawa-Ogawa M; Okano HJ
Sci Rep; 2021 Apr; 11(1):8720. PubMed ID: 33888768
[TBL] [Abstract][Full Text] [Related]
34. Multi-phaseted problems of TDP-43 in selective neuronal vulnerability in ALS.
Asakawa K; Handa H; Kawakami K
Cell Mol Life Sci; 2021 May; 78(10):4453-4465. PubMed ID: 33709256
[TBL] [Abstract][Full Text] [Related]
35. Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS.
Farrawell NE; McAlary L; Lum JS; Chisholm CG; Warraich ST; Blair IP; Vine KL; Saunders DN; Yerbury JJ
iScience; 2020 Nov; 23(11):101700. PubMed ID: 33196025
[TBL] [Abstract][Full Text] [Related]
36. Frontotemporal dementia-linked P112H mutation of TDP-43 induces protein structural change and impairs its RNA binding function.
Agrawal S; Jain M; Yang WZ; Yuan HS
Protein Sci; 2021 Feb; 30(2):350-365. PubMed ID: 33151007
[TBL] [Abstract][Full Text] [Related]
37. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
[TBL] [Abstract][Full Text] [Related]
38. Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis.
Floare ML; Allen SP
Neurosci Insights; 2020; 15():2633105520957302. PubMed ID: 32995749
[TBL] [Abstract][Full Text] [Related]
39. Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation.
Fernandes N; Nero L; Lyons SM; Ivanov P; Mittelmeier TM; Bolger TA; Buchan JR
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992901
[TBL] [Abstract][Full Text] [Related]
40. Loss of angiogenin function is related to earlier ALS onset and a paradoxical increase in ALS duration.
Aluri KC; Salisbury JP; Prehn JHM; Agar JN
Sci Rep; 2020 Feb; 10(1):3715. PubMed ID: 32111867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
